https://www.pharmaradar360.com/article/drug-label-update-unspecified-product-8fa44caec5530ce6Pharma Surgeen2026-06-23T00:00:00.000ZDrug label update: unspecified producthttps://www.pharmaradar360.com/article/clinical-and-histopathological-profile-of-breast-cancer-based-on-her2-stratifica-3865eb61b3cd6f94Pharma Surgeen2026-06-23T00:00:00.000ZClinical and Histopathological Profile of Breast Cancer Based on HER2 Stratification ASCO/CAP 2018: Analysis of HER2-Positive, Negative, Low, and Ultralowhttps://www.pharmaradar360.com/article/garengeot-hernia-preperitoneal-approach-in-the-context-of-strangulation-case-rep-23e74bd2a9a1ad57Pharma Surgeen2026-06-23T00:00:00.000ZGarengeot hernia: preperitoneal approach in the context of strangulation, case reporthttps://www.pharmaradar360.com/article/does-the-use-of-liposomal-bupivacaine-in-hip-fracture-surgery-have-any-advantage-f6982e4c584955f5Pharma Surgeen2026-06-23T00:00:00.000ZDoes the Use of Liposomal Bupivacaine in Hip Fracture Surgery Have Any Advantage Over Conventional Analgesia for Postoperative Pain Control?https://www.pharmaradar360.com/article/early-procalcitonin-kinetics-and-28-day-mortality-in-critical-illness-a-pragmati-02c9af63363a52b3Pharma Surgeen2026-06-23T00:00:00.000ZEarly procalcitonin kinetics and 28-day mortality in critical illness: a pragmatic Bayesian modelling approachhttps://www.pharmaradar360.com/article/national-comparability-and-inter-laboratory-performance-of-cortisol-immunoassays-737d636594b4166aPharma Surgeen2026-06-23T00:00:00.000ZNational comparability and inter-laboratory performance of cortisol immunoassays and LC-MS/MS methodshttps://www.pharmaradar360.com/article/enhancing-the-norepinephrine-transporter-expression-and-lt-sup-gt-211-lt-sup-gt-b4be4d97fb686b5cPharma Surgeen2026-06-23T00:00:00.000ZEnhancing the Norepinephrine Transporter Expression and [<sup>211</sup>At]MABG Uptake with Vorinostat Preloading in the Pheochromocytoma Modelhttps://www.pharmaradar360.com/article/lipopolysaccharide-induced-changes-in-facial-expression-and-orofacial-movement-i-26681344f2d0a333Pharma Surgeen2026-06-23T00:00:00.000ZLipopolysaccharide-Induced Changes in Facial Expression and Orofacial Movement in Micehttps://www.pharmaradar360.com/article/clinical-electrophysiological-and-neuropathological-features-of-peripheral-neuro-a5078c8d6d410f32Pharma Surgeen2026-06-23T00:00:00.000ZClinical, Electrophysiological, and Neuropathological Features of Peripheral Neuropathies in People With T-Cell Lymphoproliferative Disorderhttps://www.pharmaradar360.com/article/clinical-reasoning-a-32-year-old-woman-with-progressive-vision-loss-and-confusio-191667e5dc6f22e5Pharma Surgeen2026-06-23T00:00:00.000ZClinical Reasoning: A 32-Year-Old Woman With Progressive Vision Loss and Confusionhttps://www.pharmaradar360.com/article/clinical-outcomes-and-parental-of-two-stainless-steel-crown-systems-in-pediatric-e4dc2189d250e2d7Pharma Surgeen2026-06-23T00:00:00.000ZClinical outcomes and parental of two stainless steel crown systems in pediatric patients: a retrospective observational cohort studyhttps://www.pharmaradar360.com/article/low-dose-intrathecal-morphine-versus-intrathecal-fentanyl-for-post-caesarean-ana-8257ba3ef8bb526fPharma Surgeen2026-06-23T00:00:00.000ZLow-dose intrathecal morphine versus intrathecal fentanyl for post-caesarean analgesia in a resource-constrained setting: a pragmatic randomised trialhttps://www.pharmaradar360.com/article/a-slow-regular-rhythm-after-tavr-a-clinical-reasoning-exercise-5b37a5ccbaab2da6Pharma Surgeen2026-06-23T00:00:00.000ZA Slow Regular Rhythm After TAVR: A Clinical Reasoning Exercisehttps://www.pharmaradar360.com/article/angiotensin-receptor-neprilysin-inhibitor-in-heart-failure-with-preserved-ejecti-eba015785baed931Pharma Surgeen2026-06-23T00:00:00.000ZAngiotensin Receptor Neprilysin Inhibitor in Heart Failure With Preserved Ejection Fraction and Secondary Mitral Regurgitation: The PRAISE-MR Randomized Trialhttps://www.pharmaradar360.com/article/laroprovstat-the-first-oral-small-molecule-pcsk9-inhibitor-for-the-treatment-of-5ab6a734084092d7Pharma Surgeen2026-06-23T00:00:00.000ZLaroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naïve Patientshttps://www.pharmaradar360.com/article/active-and-passive-knitting-rhythm-on-eeg-909cd8ff72f7e7bePharma Surgeen2026-06-23T00:00:00.000ZActive and Passive Knitting Rhythm on EEGhttps://www.pharmaradar360.com/article/anatomy-and-structural-connectivity-of-the-opercula-43c308627870f779Pharma Surgeen2026-06-23T00:00:00.000ZAnatomy and Structural Connectivity of the Operculahttps://www.pharmaradar360.com/article/navigating-hantavirus-risk-in-transplantation-implications-for-clinical-practice-9678c597609254d1Pharma Surgeen2026-06-23T00:00:00.000ZNavigating Hantavirus Risk in Transplantation: Implications for Clinical Practicehttps://www.pharmaradar360.com/article/effect-of-a-liquid-crystal-vein-locator-on-intravenous-catheterization-in-young-43e4ca188cb0700dPharma Surgeen2026-06-23T00:00:00.000ZEffect of a liquid crystal vein locator on intravenous catheterization in young children: a randomized trialhttps://www.pharmaradar360.com/article/auditory-involvement-in-inflammatory-bowel-disease-clinical-predictors-and-progn-7d25a828ef951125Pharma Surgeen2026-06-23T00:00:00.000ZAuditory Involvement in Inflammatory Bowel Disease: Clinical Predictors and Prognostic Implicationshttps://www.pharmaradar360.com/article/home-based-trimodal-prehabilitation-before-lung-resection-a-single-center-random-20766de38d39e2eePharma Surgeen2026-06-23T00:00:00.000ZHome-based trimodal prehabilitation before lung resection: a single-center randomized controlled trialhttps://www.pharmaradar360.com/article/a-commentary-on-clinical-outcomes-of-norepinephrine-phenylephrine-vs-norepinephr-c82a0742df1a61f7Pharma Surgeen2026-06-23T00:00:00.000ZA commentary on “Clinical outcomes of norepinephrine-phenylephrine vs. norepinephrine-vasopressin in septic shock: a retrospective cohort study”https://www.pharmaradar360.com/article/excerpts-from-march-april-2025-issue-of-acce-news-0e93327c8e86f993Pharma Surgeen2026-06-23T00:00:00.000ZExcerpts from March-April 2025 Issue of ACCE Newshttps://www.pharmaradar360.com/article/risk-management-7-safety-service-contract-management-ad357e6c88415d57Pharma Surgeen2026-06-23T00:00:00.000ZRisk Management 7 Safety Service Contract Managementhttps://www.pharmaradar360.com/article/doctronic-raises-40-billion-in-series-b-funding-4553886b441da389Pharma Surgeen2026-06-23T00:00:00.000ZDoctronic Raises $40 Billion in Series B Fundinghttps://www.pharmaradar360.com/article/osu-chs-tops-us-news-rankings-in-serving-health-care-shortage-areas-3d2a35bfa6f51abcPharma Surgeen2026-06-23T00:00:00.000ZOSU-CHS Tops US News Rankings in Serving Health Care Shortage Areashttps://www.pharmaradar360.com/article/circa-scientific-inc-appoints-medtech-executive-vafa-jamali-to-board-of-director-781a2e622a0e39caPharma Surgeen2026-06-23T00:00:00.000ZCIRCA Scientific, Inc. Appoints MedTech Executive Vafa Jamali to Board of Directorshttps://www.pharmaradar360.com/article/the-qsmr-shift-why-htm-is-the-new-frontline-of-hospital-risk-bef3bc8bb3c850aePharma Surgeen2026-06-23T00:00:00.000ZThe QSMR Shift: Why HTM Is the New Frontline of Hospital Riskhttps://www.pharmaradar360.com/article/reasons-for-different-laboratory-results-in-northern-sudan-case-study-in-merowe-3e9a6fa60b9006abPharma Surgeen2026-06-23T00:00:00.000ZReasons for Different Laboratory Results in Northern Sudan (Case Study in Merowe)https://www.pharmaradar360.com/article/transfer-learning-for-low-resource-genomic-mutation-detection-84b7c8196cb3e15bPharma Surgeen2026-06-23T00:00:00.000ZTransfer Learning for Low-resource Genomic Mutation Detectionhttps://www.pharmaradar360.com/article/response-to-panteghini-about-analytical-performance-specifications-for-immunosup-4e8f23e0fdb2702cPharma Surgeen2026-06-23T00:00:00.000ZResponse to Panteghini “About Analytical Performance Specifications for Immunosuppressive Drug Measurements”https://www.pharmaradar360.com/article/postsurgical-care-in-nail-surgery-recommendations-based-on-evidence-and-clinical-182f28ccfe2ce5f6Pharma Surgeen2026-06-23T00:00:00.000ZPostsurgical Care in Nail Surgery: Recommendations Based on Evidence and Clinical Experiencehttps://www.pharmaradar360.com/article/are-age-based-cutoffs-for-tha-logically-consistent-881f6dfe5985adb0Pharma Surgeen2026-06-23T00:00:00.000ZAre Age-based Cutoffs for THA Logically Consistent?https://www.pharmaradar360.com/article/corr-insights-are-lgbtq-allyship-symbols-associated-with-patient-trust-in-the-or-13e925a5551b5e3aPharma Surgeen2026-06-23T00:00:00.000ZCORR Insights®: Are LGBTQ+ Allyship Symbols Associated With Patient Trust in the Orthopaedic Surgeon? A Dual Cohort Surveyhttps://www.pharmaradar360.com/article/preoperative-distal-motor-latency-testing-and-long-term-outcomes-in-combined-lum-0bdb8751df8f878cPharma Surgeen2026-06-23T00:00:00.000ZPreoperative Distal Motor Latency Testing and Long-Term Outcomes in Combined Lumbar Spinal Stenosishttps://www.pharmaradar360.com/article/clinical-accuracy-and-applications-of-large-language-models-in-pediatric-orthope-64467496eb7263b3Pharma Surgeen2026-06-23T00:00:00.000ZClinical accuracy and applications of large language models in pediatric orthopedics: a systematic reviewhttps://www.pharmaradar360.com/article/comparative-10-year-performance-of-mammography-artificial-intelligence-polygenic-d1287b6b520cdd2cPharma Surgeen2026-06-23T00:00:00.000ZComparative 10-year performance of mammography artificial intelligence, polygenic, and clinical breast cancer risk models in the Kaiser Permanente Research Bankhttps://www.pharmaradar360.com/article/heart-failure-inequality-and-the-decades-before-admission-2f3e36c67478b065Pharma Surgeen2026-06-23T00:00:00.000ZHeart failure, inequality, and the decades before admissionhttps://www.pharmaradar360.com/article/efficacy-and-safety-of-infigratinib-in-patients-with-refractory-advanced-gastric-33d7f14c42dc93a7Pharma Surgeen2026-06-23T00:00:00.000ZEfficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trialhttps://www.pharmaradar360.com/article/from-relapse-to-survival-real-world-clinical-impact-of-a-multimodal-approach-in-959cfed93bd0cc14Pharma Surgeen2026-06-23T00:00:00.000ZFrom relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastomahttps://www.pharmaradar360.com/article/test-post-3d12995c1a7d7bf2Pharma Surgeen2026-06-22T16:11:40.000ZTest posthttps://www.pharmaradar360.com/article/enjoy-the-hot-weather-but-stay-safe-nhsggc-advice-for-mini-heatwave-95b7abe003760c56Pharma Surgeen2026-06-22T15:45:00.000ZEnjoy the hot weather but stay safe: NHSGGC advice for mini-heatwavehttps://www.pharmaradar360.com/article/2026-un-high-level-meeting-on-hiv-aids-2d236c15b6583a34Pharma Surgeen2026-06-22T15:43:16.000Z2026 UN High-Level Meeting on HIV/AIDShttps://www.pharmaradar360.com/article/dhsc-spending-over-500-9d0eec9bf491adbdPharma Surgeen2026-06-22T15:31:28.000ZDHSC spending over £500https://www.pharmaradar360.com/article/dhsc-spending-over-500-may-2026-db6ae840e2e515bePharma Surgeen2026-06-22T15:31:20.000ZDHSC: spending over £500, May 2026https://www.pharmaradar360.com/article/machine-learning-based-drug-renal-clearance-predictor-development-and-applicatio-88cc40c758f9c7ffPharma Surgeen2026-06-22T15:20:42.000ZMachine Learning based drug renal clearance predictor development and applicationhttps://www.pharmaradar360.com/article/chemaxon-retires-jchem-for-office-lite-da9f717867504070Pharma Surgeen2026-06-22T15:17:17.000ZChemaxon retires JChem for Office Litehttps://www.pharmaradar360.com/article/why-do-some-children-get-sicker-from-the-flu-than-other-kids-and-how-do-vaccines-74cb40238c44138aPharma Surgeen2026-06-22T15:17:14.000ZWhy Do Some Children Get Sicker From the Flu Than Other Kids and How Do Vaccines Play a Role?https://www.pharmaradar360.com/article/ukhsa-privacy-notice-0e7ed345cb406e76Pharma Surgeen2026-06-22T15:06:08.000ZUKHSA privacy noticehttps://www.pharmaradar360.com/article/lilly-declares-third-quarter-2026-dividend-78b7482ce78a846fPharma Surgeen2026-06-22T15:00:00.000ZLilly declares third-quarter 2026 dividendhttps://www.pharmaradar360.com/article/letter-to-baroness-casey-progress-on-adult-social-care-reform-recommendations-e4ba38a0b5ae62cePharma Surgeen2026-06-22T14:39:55.000ZLetter to Baroness Casey: progress on adult social care reform recommendationshttps://www.pharmaradar360.com/article/menb-vaccination-eligible-residential-further-education-settings-ea1c926b97083608Pharma Surgeen2026-06-22T14:31:58.000ZMenB vaccination: eligible residential further education settingshttps://www.pharmaradar360.com/article/women-s-college-hospital-launches-trauma-therapy-network-of-ontario-16caf432205dd826Pharma Surgeen2026-06-22T14:24:54.000ZWomen’s College Hospital launches Trauma Therapy Network of Ontariohttps://www.pharmaradar360.com/article/vaccine-update-issue-371-may-2026-nin-special-35bf814080bca537Pharma Surgeen2026-06-22T14:10:15.000ZVaccine update: issue 371, May 2026, NIN specialhttps://www.pharmaradar360.com/article/volontariato-28-06-un-concerto-per-sostenere-l-associazione-amici-della-clinica-9f7a522d273e777cPharma Surgeen2026-06-22T14:00:00.000Z#VOLONTARIATO [28.06] Un concerto per sostenere l'Associazione Amici della Clinica Neurochirurgicahttps://www.pharmaradar360.com/article/pride-month-clinical-research-as-activism-92d0a7b7716cb2dbPharma Surgeen2026-06-22T13:22:07.000ZPride Month: Clinical Research as Activismhttps://www.pharmaradar360.com/article/wissenschaftsjahr-2026-vier-forderprojekte-zur-wissenschaftskommunikation-in-hei-203cc78b0448f0acPharma Surgeen2026-06-22T13:13:41.000ZWissenschaftsjahr 2026: Vier Förderprojekte zur Wissenschaftskommunikation in Heidelberg und Mannheimhttps://www.pharmaradar360.com/article/genetische-diagnostik-leicht-erklart-mit-generation-genom-dein-code-deine-zukunf-9cd6add8b5a67f4aPharma Surgeen2026-06-22T13:13:12.000ZGenetische Diagnostik leicht erklärt mit „Generation Genom – Dein Code. Deine Zukunft.“https://www.pharmaradar360.com/article/von-a-wie-adhs-bis-z-wie-zukunftsangst-social-media-projekt-klart-zu-psychischer-635933a36252d2a7Pharma Surgeen2026-06-22T13:12:45.000ZVon A wie ADHS bis Z wie Zukunftsangst: Social-Media-Projekt klärt zu psychischer Gesundheit aufhttps://www.pharmaradar360.com/article/mit-rollenspielen-digitale-medizin-erleben-77d482feb31a8744Pharma Surgeen2026-06-22T13:12:19.000ZMit Rollenspielen digitale Medizin erlebenhttps://www.pharmaradar360.com/article/healthscience4all-gemeinsam-gesundheit-machen-dced272207476e45Pharma Surgeen2026-06-22T13:11:00.000Z„HealthScience4All“: Gemeinsam Gesundheit machenhttps://www.pharmaradar360.com/article/education-alumnae-lead-cheers-in-canes-crew-2caf84bb2bf5e5cdPharma Surgeen2026-06-22T12:58:24.000ZEducation alumnae lead cheers in Canes Crewhttps://www.pharmaradar360.com/article/dhsc-one-off-statistical-releases-a8a8056e5d3d3dabPharma Surgeen2026-06-22T12:34:11.000ZDHSC one-off statistical releaseshttps://www.pharmaradar360.com/article/estimated-impact-of-the-introduction-of-the-single-patient-record-b914a47d046c4557Pharma Surgeen2026-06-22T12:33:00.000ZEstimated impact of the introduction of the single patient recordhttps://www.pharmaradar360.com/article/a-common-vitamin-could-help-fight-one-of-the-deadliest-brain-cancers-d23e540015c0efe6Pharma Surgeen2026-06-22T12:23:53.000ZA common vitamin could help fight one of the deadliest brain cancershttps://www.pharmaradar360.com/article/cough-cold-4e1edfaeb8bb579ePharma Surgeen2026-06-22T12:19:57.000ZCough & coldhttps://www.pharmaradar360.com/article/pain-management-dafd5b7f540add05Pharma Surgeen2026-06-22T12:19:57.000ZPain managementhttps://www.pharmaradar360.com/article/neurology-63b31e258c2d37e4Pharma Surgeen2026-06-22T12:19:57.000ZNeurologyhttps://www.pharmaradar360.com/article/cardiometabolic-aa6d4587a7321130Pharma Surgeen2026-06-22T12:19:57.000ZCardiometabolichttps://www.pharmaradar360.com/article/intim-health-5abe91496210d596Pharma Surgeen2026-06-22T12:19:57.000ZIntim healthhttps://www.pharmaradar360.com/article/gastroenterology-2257d60486d8dee0Pharma Surgeen2026-06-22T12:19:57.000ZGastroenterologyhttps://www.pharmaradar360.com/article/skin-care-ac1ea4a775c70d07Pharma Surgeen2026-06-22T12:19:57.000ZSkin carehttps://www.pharmaradar360.com/article/antibiotics-and-antiseptics-fad87fe3a4f2fedcPharma Surgeen2026-06-22T12:19:57.000ZAntibiotics and antisepticshttps://www.pharmaradar360.com/article/drugs-for-allergy-2fbb7bd128b0ddabPharma Surgeen2026-06-22T12:19:57.000ZDrugs for Allergyhttps://www.pharmaradar360.com/article/fb09a81eb57f8349Pharma Surgeen2026-06-22T12:19:57.000ZПрепарати від застуди та температуриhttps://www.pharmaradar360.com/article/63a817099fb88e7dPharma Surgeen2026-06-22T12:19:57.000ZПрепарати від болю та запаленняhttps://www.pharmaradar360.com/article/c99b583417679c1fPharma Surgeen2026-06-22T12:19:57.000ZНеврологічні препаратиhttps://www.pharmaradar360.com/article/215a3c23a9f76c2bPharma Surgeen2026-06-22T12:19:57.000ZКардіометаболічні препаратиhttps://www.pharmaradar360.com/article/180fc30068f63441Pharma Surgeen2026-06-22T12:19:57.000ZПрепарати для інтимного здоров'яhttps://www.pharmaradar360.com/article/bc702cacb4e44471Pharma Surgeen2026-06-22T12:19:57.000ZПрепарати для застосування у хірургіїhttps://www.pharmaradar360.com/article/6e6d58256e2049adPharma Surgeen2026-06-22T12:19:57.000ZГастроентерологічні препаратиhttps://www.pharmaradar360.com/article/8675dc58a4d32d6cPharma Surgeen2026-06-22T12:19:57.000ZДерматологічні препаратиhttps://www.pharmaradar360.com/article/ee3027f2271a1fa8Pharma Surgeen2026-06-22T12:19:57.000ZАнтибактеріальні препарати та антисептикиhttps://www.pharmaradar360.com/article/d94f61326c64b043Pharma Surgeen2026-06-22T12:19:57.000ZПрепарати при алергіїhttps://www.pharmaradar360.com/article/b3f3f978e8181105Pharma Surgeen2026-06-22T12:19:57.000ZПрепаратиhttps://www.pharmaradar360.com/article/usz-erhalt-fordergelder-zur-erforschung-von-herzmuskelerkrankungen-9afa8ef28c2ec9daPharma Surgeen2026-06-22T12:14:46.000ZUSZ erhält Fördergelder zur Erforschung von Herzmuskelerkrankungenhttps://www.pharmaradar360.com/article/designing-a-comprehensive-pipeline-for-crispr-safety-evaluation-6d2d6db9917b32bePharma Surgeen2026-06-22T12:00:00.000ZDesigning a Comprehensive Pipeline for CRISPR Safety Evaluationhttps://www.pharmaradar360.com/article/andrew-mcewan-consultant-2b597fc76d49a217Pharma Surgeen2026-06-22T11:55:26.000ZAndrew McEwan - Consultanthttps://www.pharmaradar360.com/article/german-cancer-award-for-scientists-at-the-medical-faculty-heidelberg-a93243caaa070438Pharma Surgeen2026-06-22T11:49:38.000ZGerman Cancer Award for Scientists at the Medical Faculty Heidelberghttps://www.pharmaradar360.com/article/using-ai-to-close-the-post-market-design-loop-greenlight-guru-cb53504b2f3062c9Pharma Surgeen2026-06-22T11:40:35.000ZUsing AI to close the post-market design loop | Greenlight Guruhttps://www.pharmaradar360.com/article/from-fragmented-reporting-to-real-time-foresight-what-the-fda-s-aems-means-for-p-16c11c54d07fea9cPharma Surgeen2026-06-22T11:35:24.000ZFrom fragmented reporting to real-time foresight: What the FDA’s AEMS means for pharmacovigilancehttps://www.pharmaradar360.com/article/les-hopitaux-universitaires-de-strasbourg-remportent-le-challenge-des-foulees-ec-bf6b779392b0daabPharma Surgeen2026-06-22T11:35:15.000ZLes Hôpitaux Universitaires de Strasbourg remportent le Challenge des Foulées éco-solidaires pour la deuxième année consécutivehttps://www.pharmaradar360.com/article/les-hus-informent-et-accompagnent-les-patients-atteints-d-un-cancer-du-rein-a901820ea576070dPharma Surgeen2026-06-22T11:32:58.000ZLes HUS informent et accompagnent les patients atteints d’un cancer du reinhttps://www.pharmaradar360.com/article/covid-19-vaccination-spring-2026-campaign-resources-6896042b62ccb70dPharma Surgeen2026-06-22T11:25:40.000ZCOVID-19 vaccination: spring 2026 campaign resourceshttps://www.pharmaradar360.com/article/uk-public-health-rapid-support-team-uk-phrst-e9ece4baa927d83dPharma Surgeen2026-06-22T11:21:22.000ZUK Public Health Rapid Support Team (UK-PHRST)https://www.pharmaradar360.com/article/respiratory-syncytial-virus-rsv-vaccination-for-older-adults-b709407e14b34df9Pharma Surgeen2026-06-22T11:19:44.000ZRespiratory syncytial virus (RSV): vaccination for older adultshttps://www.pharmaradar360.com/article/exclusive-nsf-slashes-research-programs-to-support-new-tech-initiative-insiders-efd3e7eb7a1eff80Pharma Surgeen2026-06-22T11:15:00.000ZExclusive: NSF slashes research programs to support new tech initiative, insiders sayhttps://www.pharmaradar360.com/article/ukhsa-issues-red-heat-health-alerts-across-england-3ab1f8a5ec9bfc1dPharma Surgeen2026-06-22T11:01:07.000ZUKHSA issues red heat-health alerts across Englandhttps://www.pharmaradar360.com/article/abbvie-to-acquire-apogee-therapeutics-deepening-immunology-portfolio-9b2e7536a11549b2Pharma Surgeen2026-06-22T11:00:00.000ZAbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfoliohttps://www.pharmaradar360.com/article/labcorp-announces-nationwide-availability-of-colosense-the-first-fda-approved-rn-068f3933db6b7cf8Pharma Surgeen2026-06-22T11:00:00.000ZLabcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Screening Testhttps://www.pharmaradar360.com/article/ukhsa-update-on-the-hantavirus-cruise-ship-outbreak-3c646fc27267b263Pharma Surgeen2026-06-22T10:52:28.000ZUKHSA update on the hantavirus cruise ship outbreakhttps://www.pharmaradar360.com/article/renewal-of-vmps-2026-fcd9b4de0763265cPharma Surgeen2026-06-22T10:47:42.000ZRENEWAL OF VMPs 2026https://www.pharmaradar360.com/article/merck-s-tulisokibart-met-primary-and-key-secondary-endpoints-in-the-phase-3-atla-85af5c6c78bad7b8Pharma Surgeen2026-06-22T10:45:00.000ZMerck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC)https://www.pharmaradar360.com/article/2026-e15cba17a9db6bebPharma Surgeen2026-06-22T10:42:43.000ZΑΝΑΝΕΩΣΕΙΣ ΚΤΗΝΙΑΤΡΙΚΩΝ ΠΡΟΪΟΝΤΩΝ 2026https://www.pharmaradar360.com/article/butterfly-that-barely-ages-could-help-unlock-longevity-secrets-595f4da50f791637Pharma Surgeen2026-06-22T10:30:08.000ZButterfly that barely ages could help unlock longevity secretshttps://www.pharmaradar360.com/article/icon-selects-microsoft-as-a-preferred-technology-partner-to-power-ai-enabled-cli-6d62bb6d794b913dPharma Surgeen2026-06-22T09:53:36.000ZICON Selects Microsoft as a Preferred Technology Partner to Power AI-Enabled Clinical Developmenthttps://www.pharmaradar360.com/article/heidelberg-among-the-top-three-universities-in-germany-c0776f33e63073ecPharma Surgeen2026-06-22T09:52:53.000ZHeidelberg Among the “Top Three” Universities in Germanyhttps://www.pharmaradar360.com/article/weekly-all-cause-mortality-surveillance-week-ending-21-june-2026-6a0eead6dccb0816Pharma Surgeen2026-06-22T09:35:35.000ZWeekly all-cause mortality surveillance: week ending 21 June 2026https://www.pharmaradar360.com/article/world-refugee-day-showing-solidarity-with-refugees-in-south-africa-1c171c82a338e056Pharma Surgeen2026-06-22T09:14:19.000ZWorld Refugee Day: Showing solidarity with refugees in South Africahttps://www.pharmaradar360.com/article/what-the-first-joint-clinical-assessment-jca-report-tells-us-about-the-next-era-798d89dcf0acdf20Pharma Surgeen2026-06-22T09:11:56.000ZWhat the first Joint Clinical Assessment (JCA) report tells us about the next era of integrated evidence planning and access strategyhttps://www.pharmaradar360.com/article/la-adquisicion-de-rois-phoenix-marca-un-nuevo-hito-en-la-internacionalizacion-de-2fa01139f7d26eabPharma Surgeen2026-06-22T09:11:14.000ZLa adquisición de ROIS PHOENIX marca un nuevo hito en la internacionalización del negocio de fabricación a terceros de ROIShttps://www.pharmaradar360.com/article/women-living-with-ms-take-to-the-stage-in-powerful-showcase-7f459939722c5587Pharma Surgeen2026-06-22T09:03:17.000ZWomen living with MS take to the stage in powerful showcasehttps://www.pharmaradar360.com/article/does-drinking-juice-soda-during-childhood-increase-the-risk-of-high-blood-pressu-7ecd15e132fabe8ePharma Surgeen2026-06-22T09:00:00.000ZDoes drinking juice, soda during childhood increase the risk of high blood pressure?https://www.pharmaradar360.com/article/algae-microbots-take-aim-at-bladder-cancer-7c544810e644309fPharma Surgeen2026-06-22T08:51:26.000ZAlgae microbots take aim at bladder cancerhttps://www.pharmaradar360.com/article/post-covid-syndrom-blutwasche-zeigt-in-studie-keinen-nutzen-fur-betroffene-8aec8256c4d917c0Pharma Surgeen2026-06-22T08:31:45.000ZPost-Covid-Syndrom: Blutwäsche zeigt in Studie keinen Nutzen für Betroffenehttps://www.pharmaradar360.com/article/research-as-a-constant-balancing-act-between-opportunities-and-risks-f86e89733ba4237bPharma Surgeen2026-06-22T08:20:09.000ZResearch as a Constant Balancing Act between Opportunities and Riskshttps://www.pharmaradar360.com/article/muttermilch-fur-fruhgeborene-7f4dfe8063e439dePharma Surgeen2026-06-22T08:13:10.000ZMuttermilch für Frühgeborenehttps://www.pharmaradar360.com/article/acuerdos-aprobados-y-votaciones-6a9c9d85a3a28004Pharma Surgeen2026-06-22T08:11:47.000ZAcuerdos aprobados y votacioneshttps://www.pharmaradar360.com/article/ai-tool-reveals-hidden-organ-damage-caused-by-high-blood-pressure-d26a1ebe0f5d8484Pharma Surgeen2026-06-22T08:00:42.000ZAI tool reveals hidden organ damage caused by high blood pressurehttps://www.pharmaradar360.com/article/hydration-break-advertising-signals-a-lasting-shift-in-global-football-2c4fe8a51b6eea74Pharma Surgeen2026-06-22T08:00:00.000ZHydration break advertising signals a lasting shift in global footballhttps://www.pharmaradar360.com/article/2026-3-4-7-24-20dc904f5aeba21bPharma Surgeen2026-06-22T07:41:22.000Z2026年度 第3回・第4回 臨床研究教育セミナー開催のお知らせ（7/24開催）https://www.pharmaradar360.com/article/information-about-the-criminal-offence-committed-by-a-former-employee-of-the-uni-ee060b2d6ee29a14Pharma Surgeen2026-06-22T07:08:00.000ZInformation about the criminal offence committed by a former employee of the University of Freiburghttps://www.pharmaradar360.com/article/holland-chair-spurs-innovation-in-public-health-1e60892ce4c00a6ePharma Surgeen2026-06-22T07:00:00.000ZHolland chair spurs innovation in public healthhttps://www.pharmaradar360.com/article/between-heat-exhaustion-and-heat-stroke-what-you-need-to-know-b5fac13ff19ea0b9Pharma Surgeen2026-06-22T07:00:00.000ZBetween Heat Exhaustion and Heat Stroke: What You Need to Knowhttps://www.pharmaradar360.com/article/unmc-team-publishes-review-article-on-hantavirus-6569e837d3eb2a4dPharma Surgeen2026-06-22T06:58:00.000ZUNMC team publishes review article on Hantavirushttps://www.pharmaradar360.com/article/new-faculty-spotlight-logan-kludt-lawrence-dds-a684a1a813941e79Pharma Surgeen2026-06-22T06:56:00.000ZNew faculty spotlight: Logan Kludt Lawrence, DDShttps://www.pharmaradar360.com/article/ebola-and-hantavirus-can-start-like-the-flu-but-turn-deadly-fast-c41bcd1a3639caaePharma Surgeen2026-06-22T06:30:53.000ZEbola and hantavirus can start like the flu but turn deadly fasthttps://www.pharmaradar360.com/article/skydda-dig-infor-resan-se-over-ditt-vaccinationsskydd-e596a86c455487dcPharma Surgeen2026-06-22T06:16:52.000ZSkydda dig inför resan – se över ditt vaccinationsskyddhttps://www.pharmaradar360.com/article/year-to-date-business-update-ahead-of-annual-general-meeting-40631478ea36b1eaPharma Surgeen2026-06-22T06:02:08.000ZYear-to-date business update ahead of Annual General Meetinghttps://www.pharmaradar360.com/article/comment-la-production-hepatique-d-epo-s-eteint-a-la-naissance-24dfced76484851fPharma Surgeen2026-06-22T06:00:00.000ZComment la production hépatique d’EPO s’éteint à la naissancehttps://www.pharmaradar360.com/article/dermatite-eczema-e-scottatura-l-abc-delle-irritazioni-della-pelle-4f84152ee8e319fdPharma Surgeen2026-06-22T05:58:00.000ZDermatite, eczema e scottatura: l'ABC delle irritazioni della pellehttps://www.pharmaradar360.com/article/2027-tour-de-cure-mid-atlantic-cbdfd4a4a883db5cPharma Surgeen2026-06-22T05:14:19.000Z2027 Tour de Cure®: Mid-Atlantichttps://www.pharmaradar360.com/article/2027-tour-de-cure-florida-0fa5e13cec6c739dPharma Surgeen2026-06-22T05:14:19.000Z2027 Tour de Cure®: Floridahttps://www.pharmaradar360.com/article/2027-tour-de-cure-arizona-0efea63f938482ccPharma Surgeen2026-06-22T05:14:19.000Z2027 Tour de Cure®: Arizonahttps://www.pharmaradar360.com/article/2027-step-out-walk-tennessee-1800ca0610479d64Pharma Surgeen2026-06-22T05:14:19.000Z2027 Step Out® Walk: Tennesseehttps://www.pharmaradar360.com/article/2027-step-out-walk-tampa-d991751ab8ce02aePharma Surgeen2026-06-22T05:14:19.000Z2027 Step Out® Walk: Tampahttps://www.pharmaradar360.com/article/2027-step-out-walk-north-texas-62b162c70317fadaPharma Surgeen2026-06-22T05:14:19.000Z2027 Step Out® Walk: North Texashttps://www.pharmaradar360.com/article/2027-step-out-walk-hawaii-12b2b04c8c4c8298Pharma Surgeen2026-06-22T05:14:19.000Z2027 Step Out® Walk: Hawaiihttps://www.pharmaradar360.com/article/2027-step-out-walk-charlotte-9a1e7a1e11085daePharma Surgeen2026-06-22T05:14:19.000Z2027 Step Out® Walk: Charlottehttps://www.pharmaradar360.com/article/bio-2026-cell-and-gene-therapy-sector-must-break-the-mold-to-thrive-4fe03b4af8563984Pharma Surgeen2026-06-22T04:53:00.000ZBIO 2026: Cell and gene therapy sector must break the mold to thrivehttps://www.pharmaradar360.com/article/infant-resuscitation-system-correction-ge-healthcare-issues-correction-for-giraf-f6ae418a58c2d32bPharma Surgeen2026-06-22T04:00:00.000ZInfant Resuscitation System Correction: GE HealthCare Issues Correction for Giraffe and Panda Infant Resuscitation Systems and Warmers with a M1091607-R Blenderhttps://www.pharmaradar360.com/article/heart-pump-controller-correction-abiomed-updates-use-instructions-for-automated-9d680a62c9f545eaPharma Surgeen2026-06-22T04:00:00.000ZHeart Pump Controller Correction: Abiomed Updates Use Instructions for Automated Impella Controllershttps://www.pharmaradar360.com/article/shinsa-cdx-approved-for-identifying-eligible-patients-updated-june-16-2026-54d2f1b7bc99c8c4Pharma Surgeen2026-06-22T03:00:00.000Z[SHINSA]CDx approved for identifying eligible patients (Updated June 16, 2026)https://www.pharmaradar360.com/article/shinsa-list-of-approved-drugs-april-2004-to-february-2026-36a9fdbe61938f13Pharma Surgeen2026-06-22T03:00:00.000Z[SHINSA]List of Approved Drugs: April 2004 to February 2026https://www.pharmaradar360.com/article/one-common-fat-may-fuel-type-2-diabetes-while-another-helps-fight-it-d21b2205ad875829Pharma Surgeen2026-06-22T00:25:04.000ZOne common fat may fuel type 2 diabetes while another helps fight ithttps://www.pharmaradar360.com/article/abbvie-filed-form-8-k-1d7a98a5d89bf343Pharma Surgeen2026-06-22T00:00:00.000ZAbbVie filed Form 8-Khttps://www.pharmaradar360.com/article/gsk-filed-form-6-k-4bf5084d40c43e88Pharma Surgeen2026-06-22T00:00:00.000ZGSK filed Form 6-Khttps://www.pharmaradar360.com/article/sanofi-filed-form-6-k-06e50b94bb23e808Pharma Surgeen2026-06-22T00:00:00.000ZSanofi filed Form 6-Khttps://www.pharmaradar360.com/article/from-1-to-180-how-nice-guidance-helped-us-make-smarter-slide-sheet-choices-eafe070e09e65a94Pharma Surgeen2026-06-22T00:00:00.000ZFrom £1 to £180: how NICE guidance helped us make smarter slide sheet choiceshttps://www.pharmaradar360.com/article/deep-learning-enabled-single-cell-morpholomic-atlas-of-nasal-swabs-distinguishes-faa6339b9aab6bbbPharma Surgeen2026-06-22T00:00:00.000ZDeep learning–enabled single-cell morpholomic atlas of nasal swabs distinguishes chronic inflammation from sinonasal malignancyhttps://www.pharmaradar360.com/article/nucleic-sexual-hormone-receptor-signaling-pathways-in-breast-cancer-function-reg-5a0d531f78e8b3d7Pharma Surgeen2026-06-22T00:00:00.000ZNucleic sexual hormone receptor signaling pathways in breast cancer: function regulation, crosstalk, and therapeutic implicationshttps://www.pharmaradar360.com/article/long-term-health-risks-of-e-cigarettes-after-smoking-cessation-0b5010b57e88e76cPharma Surgeen2026-06-22T00:00:00.000ZLong-term health risks of e-cigarettes after smoking cessationhttps://www.pharmaradar360.com/article/a-case-of-artificial-intelligence-enhanced-diagnostics-leading-to-heart-transpla-b78475cff8c90f71Pharma Surgeen2026-06-22T00:00:00.000ZA case of artificial intelligence-enhanced diagnostics leading to heart transplantationhttps://www.pharmaradar360.com/article/biological-aging-and-generational-shifts-in-early-onset-cancer-risk-319a99ff0f8777baPharma Surgeen2026-06-22T00:00:00.000ZBiological aging and generational shifts in early-onset cancer riskhttps://www.pharmaradar360.com/article/affordable-centimeter-scale-3d-microscopy-with-submicrometer-resolution-43ce8c6e9ee3f64fPharma Surgeen2026-06-22T00:00:00.000ZAffordable centimeter-scale 3D microscopy with submicrometer resolutionhttps://www.pharmaradar360.com/article/c-glycoside-synthesis-via-radical-cross-coupling-of-glycohydrazides-584fecfc4c41efb3Pharma Surgeen2026-06-22T00:00:00.000ZC-glycoside synthesis via radical cross-coupling of glycohydrazideshttps://www.pharmaradar360.com/article/stereoretentive-decarbonylative-c-sp-3-c-sp-3-cross-coupling-8b31d8f4b39ea79bPharma Surgeen2026-06-22T00:00:00.000ZStereoretentive decarbonylative C(sp 3 )-C(sp 3 ) cross-couplinghttps://www.pharmaradar360.com/article/isotopic-evidence-for-a-cold-and-distant-origin-of-3i-atlas-edc13ada612fc167Pharma Surgeen2026-06-22T00:00:00.000ZIsotopic evidence for a cold and distant origin of 3I/ATLAShttps://www.pharmaradar360.com/article/make-science-more-reliable-study-people-as-they-go-about-their-lives-cda2ca72bab5b884Pharma Surgeen2026-06-22T00:00:00.000ZMake science more reliable: study people as they go about their liveshttps://www.pharmaradar360.com/article/why-heritage-sites-are-at-risk-in-a-warming-world-and-how-to-save-them-66d16ddfe34c4e2aPharma Surgeen2026-06-22T00:00:00.000ZWhy heritage sites are at risk in a warming world — and how to save themhttps://www.pharmaradar360.com/article/will-ai-spark-a-scientific-renaissance-or-a-diffuse-monoculture-cdbeeef43cef14d0Pharma Surgeen2026-06-22T00:00:00.000ZWill AI spark a scientific renaissance — or a diffuse monoculture?https://www.pharmaradar360.com/article/the-first-ticking-nuclear-clocks-are-here-what-can-they-do-374eea03e8011488Pharma Surgeen2026-06-22T00:00:00.000ZThe first ticking ‘nuclear clocks’ are here — what can they do?https://www.pharmaradar360.com/article/natco-records-e2-82-b9816-9-crore-consolidated-revenue-and-e2-82-b9269-0-crore-o-88765df961c41d8cPharma Surgeen2026-06-22T00:00:00.000Znatco records %e2%82%b9816 9 crore consolidated revenue and %e2%82%b9269 0 crore of profit after tax for q4 fy26 and %e2%82%b94375 9 crore of revenue %e2%82%b91418 5 crore profit after tax for fy26https://www.pharmaradar360.com/article/natco-records-e2-82-b9705-4-crore-consolidated-revenue-and-e2-82-b9151-3-crore-o-8d3a38d9a9f2c790Pharma Surgeen2026-06-22T00:00:00.000Znatco records %e2%82%b9705 4 crore consolidated revenue and %e2%82%b9151 3 crore of profit after tax for q3fy26https://www.pharmaradar360.com/article/natco-records-e2-82-b91463-crore-consolidated-revenue-and-e2-82-b9517-9-crore-of-2fd7783bb395bef5Pharma Surgeen2026-06-22T00:00:00.000Znatco records %e2%82%b91463 crore consolidated revenue and %e2%82%b9517 9 crore of profit after tax for q2fy26https://www.pharmaradar360.com/article/natco-receives-tentative-approval-for-erdafitinib-tablets-generic-of-balversa-fr-f6fb7f3135e9649cPharma Surgeen2026-06-22T00:00:00.000Znatco receives tentative approval for erdafitinib tablets generic of balversa from the united states food and drug administration u s fdahttps://www.pharmaradar360.com/article/natco-receives-approval-from-central-drug-standard-control-organisation-cdsco-fo-ecbdfd7ec8a2cb96Pharma Surgeen2026-06-22T00:00:00.000Znatco receives approval from central drug standard control organisation cdsco for semaglutide in indiahttps://www.pharmaradar360.com/article/natco-pharma-limited-api-unit-in-chennai-receives-establishment-inspection-repor-4d8866785078836ePharma Surgeen2026-06-22T00:00:00.000Znatco pharma limited api unit in chennai receives establishment inspection report eir from u s fdahttps://www.pharmaradar360.com/article/natco-pharma-launches-semaglutide-generic-injection-multi-dose-vials-in-india-at-21c68bd1a09f4cedPharma Surgeen2026-06-22T00:00:00.000Znatco pharma launches semaglutide generic injection multi dose vials in india at the most affordable price starting from mrp inr 1290https://www.pharmaradar360.com/article/natco-announces-launch-of-pomalidomide-capsules-generic-of-pomalyst-in-the-u-s-m-4e5275bcf166f9f0Pharma Surgeen2026-06-22T00:00:00.000Znatco announces launch of pomalidomide capsules generic of pomalyst in the u s markethttps://www.pharmaradar360.com/article/natco-announces-launch-of-its-everolimus-tablets-1-mg-generic-of-zortress-065a224782343c4bPharma Surgeen2026-06-22T00:00:00.000Znatco announces launch of its everolimus tablets 1 mg generic of zortresshttps://www.pharmaradar360.com/article/natco-and-lupin-receive-approval-from-u-s-fda-for-eribulin-mesylate-injection-d092fe389fffc947Pharma Surgeen2026-06-22T00:00:00.000Znatco and lupin receive approval from u s fda for eribulin mesylate injectionhttps://www.pharmaradar360.com/article/intimation-under-regulation-30-of-sebi-listing-obligations-and-disclosure-requir-354044ca1f0a8452Pharma Surgeen2026-06-22T00:00:00.000Zintimation under regulation 30 of sebi listing obligations and disclosure requirements regulations 2015 2https://www.pharmaradar360.com/article/disclosure-under-regulation-30-of-the-sebi-listing-obligations-and-disclosure-re-898c0eca335249d7Pharma Surgeen2026-06-22T00:00:00.000Zdisclosure under regulation 30 of the sebi listing obligations and disclosure requirements regulations 2015https://www.pharmaradar360.com/article/adcock-ingram-completes-delisting-from-jse-natco-pharma-acquires-35-75-stake-5c65e15922515026Pharma Surgeen2026-06-22T00:00:00.000Zadcock ingram completes delisting from jse natco pharma acquires 35 75 stakehttps://www.pharmaradar360.com/article/home-page-ada682316308b8ebPharma Surgeen2026-06-22T00:00:00.000ZHome pagehttps://www.pharmaradar360.com/article/medical-devices-gastroenterology-urology-devices-classification-of-the-endoscopi-e70250ecd2511fecPharma Surgeen2026-06-22T00:00:00.000ZMedical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Traction Devicehttps://www.pharmaradar360.com/article/medical-devices-gastroenterology-urology-devices-classification-of-the-endoscopi-7ab73981abaadc6cPharma Surgeen2026-06-22T00:00:00.000ZMedical Devices; Gastroenterology-Urology Devices; Classification of the Endoscopic Light-Projecting Measuring Devicehttps://www.pharmaradar360.com/article/medical-devices-immunology-and-microbiology-devices-classification-of-the-simple-b9602d5dde6a1c62Pharma Surgeen2026-06-22T00:00:00.000ZMedical Devices; Immunology and Microbiology Devices; Classification of the Simple In Vitro Diagnostic Device for the Detection of Secreted Proteins From Bacillus Species (spp.) in Human Clinical Sampleshttps://www.pharmaradar360.com/article/340b-rebate-model-pilot-program-application-implementation-and-evaluation-correc-3dbf1f8eaecd3680Pharma Surgeen2026-06-22T00:00:00.000Z340B Rebate Model Pilot Program Application, Implementation, and Evaluation, Correctionhttps://www.pharmaradar360.com/article/epizyme-inc-withdrawal-of-approval-of-new-drug-application-for-tazverik-tazemeto-5f649c79519bdf7cPharma Surgeen2026-06-22T00:00:00.000ZEpizyme, Inc.; Withdrawal of Approval of New Drug Application for TAZVERIK (Tazemetostat) Tablet, 200 Milligramshttps://www.pharmaradar360.com/article/nu-kraftsamlar-ki-inom-medicinsk-beredskap-113080484829c8efPharma Surgeen2026-06-22T00:00:00.000ZNu kraftsamlar KI inom medicinsk beredskaphttps://www.pharmaradar360.com/article/nobelkonferens-samlade-ledande-forskare-inom-mikrogliaforskning-079c01fb876b0f35Pharma Surgeen2026-06-22T00:00:00.000ZNobelkonferens samlade ledande forskare inom mikrogliaforskninghttps://www.pharmaradar360.com/article/ai-hjalper-till-att-hitta-nya-antibiotikakandidater-mot-lakemedelsresistent-gono-3764010e889a66daPharma Surgeen2026-06-22T00:00:00.000ZAI hjälper till att hitta nya antibiotikakandidater mot läkemedelsresistent gonorréhttps://www.pharmaradar360.com/article/carob-pod-aqueous-extract-potentiates-cisplatin-efficacy-and-reduces-toxicity-in-e769a5cf9039e7c2Pharma Surgeen2026-06-22T00:00:00.000ZCarob pod aqueous extract potentiates cisplatin efficacy and reduces toxicity in experimental hepatocellular carcinoma via mitochondrial and inflammatory pathway modulation.https://www.pharmaradar360.com/article/language-as-an-eligibility-criterion-in-pediatric-study-protocols-conducted-in-e-04f24e66b6002d43Pharma Surgeen2026-06-22T00:00:00.000ZLanguage as an Eligibility Criterion in Pediatric Study Protocols Conducted in Europe (2007-2024) Reported in the ClinicalTrials.gov Database.https://www.pharmaradar360.com/article/a-framework-for-standardising-toxicity-management-guidelines-in-oncology-clinica-31c886c0edc7dad2Pharma Surgeen2026-06-22T00:00:00.000ZA Framework for Standardising Toxicity Management Guidelines in Oncology Clinical Trials.https://www.pharmaradar360.com/article/clinical-translation-and-landscape-of-stimuli-responsive-nanomedicines-and-micro-38628c2b9771ca05Pharma Surgeen2026-06-22T00:00:00.000ZClinical translation and landscape of stimuli-responsive nanomedicines and microscale therapeutics.https://www.pharmaradar360.com/article/nct07661940-efficacy-and-safety-of-sp16-in-preventing-acute-kidney-injury-in-at-03666c9aed8425bePharma Surgeen2026-06-22T00:00:00.000ZNCT07661940: Efficacy and Safety of SP16 in Preventing Acute Kidney Injury in At-risk Subjects With Chronic Kidney Disease Undergoing Elective Cardiac Surgery Using the Heart-lung-machinehttps://www.pharmaradar360.com/article/nct07661797-phase-i-clinical-study-of-lnf2105-in-patients-with-advanced-solid-tu-c6b24d7c4988dd58Pharma Surgeen2026-06-22T00:00:00.000ZNCT07661797: Phase I Clinical Study of LNF2105 in Patients With Advanced Solid Tumorshttps://www.pharmaradar360.com/article/nct07661368-cooking-health-oriented-meals-to-prevent-dementia-and-diabetes-09705a173e96480dPharma Surgeen2026-06-22T00:00:00.000ZNCT07661368: Cooking Health-Oriented Meals to Prevent Dementia and Diabeteshttps://www.pharmaradar360.com/article/nct07660978-cognitive-based-balance-rehabilitation-in-parkinson-s-disease-virtua-d8325e6b13248209Pharma Surgeen2026-06-22T00:00:00.000ZNCT07660978: Cognitive-Based Balance Rehabilitation in Parkinson's Disease: Virtual Reality vs. Dual Taskhttps://www.pharmaradar360.com/article/nct07660289-combined-advanced-targeted-therapy-for-inflammatory-bowel-disease-e8dd6814414c25f4Pharma Surgeen2026-06-22T00:00:00.000ZNCT07660289: Combined Advanced Targeted Therapy for Inflammatory Bowel Diseasehttps://www.pharmaradar360.com/article/nct07658950-efficacy-of-intofine-joint-support-dietary-supplement-on-bone-and-jo-9fd0717cb2fb4383Pharma Surgeen2026-06-22T00:00:00.000ZNCT07658950: Efficacy of INTOFINE-JOINT SUPPORT DIETARY SUPPLEMENT on Bone and Joint Healthhttps://www.pharmaradar360.com/article/nct07574541-multitargeted-recombinant-ad5-psa-muc-1-brachyury-based-immunotherap-0f3af0b930fedd23Pharma Surgeen2026-06-22T00:00:00.000ZNCT07574541: Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillancehttps://www.pharmaradar360.com/article/nct07536308-a-safety-and-immunogenicity-trial-of-ocu500-chad36-vector-encoding-s-0e8a6e59eb441be3Pharma Surgeen2026-06-22T00:00:00.000ZNCT07536308: A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adultshttps://www.pharmaradar360.com/article/nct07485569-drug-repurposing-in-thyroid-carcinoma-a-feasibility-trial-20d7f03f31bf4923Pharma Surgeen2026-06-22T00:00:00.000ZNCT07485569: Drug Repurposing in Thyroid Carcinoma: a Feasibility Trialhttps://www.pharmaradar360.com/article/nct07379138-studying-quality-of-life-inclusive-of-mental-health-and-cognitive-be-21ce646b85750990Pharma Surgeen2026-06-22T00:00:00.000ZNCT07379138: Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patientshttps://www.pharmaradar360.com/article/nct07339046-trial-of-device-that-is-not-approved-or-cleared-by-the-u-s-fda-e28093f7630b56bfPharma Surgeen2026-06-22T00:00:00.000ZNCT07339046: [Trial of device that is not approved or cleared by the U.S. FDA]https://www.pharmaradar360.com/article/nct07318558-a-clinical-trial-of-sac-tmt-in-people-with-non-hrd-positive-advanced-1a0f8be899aec0caPharma Surgeen2026-06-22T00:00:00.000ZNCT07318558: A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)https://www.pharmaradar360.com/article/nct07216482-a-clinical-study-of-enlicitide-in-participants-with-high-cholesterol-97fbb59c25be5a0cPharma Surgeen2026-06-22T00:00:00.000ZNCT07216482: A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)https://www.pharmaradar360.com/article/nct07027826-the-esophageal-string-test-as-a-diagnostic-screening-tool-for-eosino-dc90d2edb4b0417dPharma Surgeen2026-06-22T00:00:00.000ZNCT07027826: The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in Mali and the United Stateshttps://www.pharmaradar360.com/article/nct06931717-a-clinical-study-to-assess-the-efficacy-of-adjuvant-immunotherapy-wi-e3f514bcd5c5ea8bPharma Surgeen2026-06-22T00:00:00.000ZNCT06931717: A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapyhttps://www.pharmaradar360.com/article/nct06853314-an-effectiveness-trial-of-the-prep-for-wings-study-3e1125d5328c1437Pharma Surgeen2026-06-22T00:00:00.000ZNCT06853314: An Effectiveness Trial of the PrEP for WINGS Studyhttps://www.pharmaradar360.com/article/nct06833762-clinical-and-cpet-parameters-that-predict-improvement-in-functional-f3e40a78979d60fePharma Surgeen2026-06-22T00:00:00.000ZNCT06833762: Clinical and CPET Parameters That Predict Improvement in Functional Capacity After TAVIhttps://www.pharmaradar360.com/article/nct06698640-a-trial-of-ai-powered-text-message-outreach-on-well-child-visit-comp-efac84b9b69bb539Pharma Surgeen2026-06-22T00:00:00.000ZNCT06698640: A Trial of AI-Powered Text Message Outreach on Well-Child Visit Completionhttps://www.pharmaradar360.com/article/nct06690255-trial-of-an-online-spanish-pivotal-response-treatment-training-in-au-dcdeaa7f2488df24Pharma Surgeen2026-06-22T00:00:00.000ZNCT06690255: Trial of an Online Spanish Pivotal Response Treatment Training in Autism Spectrum Disorderhttps://www.pharmaradar360.com/article/nct06591845-thorough-qt-qtc-tqt-clinical-study-to-evaluate-the-effects-of-zireso-8a5f35aef2428f47Pharma Surgeen2026-06-22T00:00:00.000ZNCT06591845: Thorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy Subjectshttps://www.pharmaradar360.com/article/nct05970172-a-study-of-roxadustat-to-treat-anemia-in-children-and-teenagers-with-67d40fb516c5daecPharma Surgeen2026-06-22T00:00:00.000ZNCT05970172: A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Diseasehttps://www.pharmaradar360.com/article/nct03097939-phase-2-trial-of-ipilimumab-and-nivolumab-in-nasopharyngeal-carcinom-915e8b5a1c297af2Pharma Surgeen2026-06-22T00:00:00.000ZNCT03097939: Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinomahttps://www.pharmaradar360.com/article/nct01168271-host-and-parasite-factors-that-influence-susceptibility-to-malaria-i-19a038949dbba4dePharma Surgeen2026-06-22T00:00:00.000ZNCT01168271: Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Malihttps://www.pharmaradar360.com/article/sputum-based-test-may-identify-drug-targets-in-asthma-and-copd-patient-care-onli-6cd4ae30be41856dPharma Surgeen2026-06-22T00:00:00.000ZSputum-Based Test May Identify Drug Targets in Asthma and COPD – Patient Care Onlinehttps://www.pharmaradar360.com/article/volontariato-22-06-cieli-azzurri-concerto-jazz-per-i-bambini-del-policlinico-di-43337617bfbc7c85Pharma Surgeen2026-06-21T23:00:00.000Z#VOLONTARIATO [22.06] Cieli Azzurri, concerto jazz per i bambini del Policlinico di Milanohttps://www.pharmaradar360.com/article/beta-blockers-why-people-are-turning-to-an-old-drug-for-high-stress-moments-510d950959cb8a6aPharma Surgeen2026-06-21T22:35:37.000ZBeta Blockers: Why People Are Turning to an Old Drug for High-Stress Momentshttps://www.pharmaradar360.com/article/built-different-the-case-for-specialized-humanoids-63c54db704a98463Pharma Surgeen2026-06-21T15:31:58.000ZBuilt Different: The Case for Specialized Humanoidshttps://www.pharmaradar360.com/article/long-lived-families-reveal-a-rare-genetic-clue-to-healthy-aging-d621bcebd8ce5086Pharma Surgeen2026-06-21T14:57:42.000ZLong-lived families reveal a rare genetic clue to healthy aginghttps://www.pharmaradar360.com/article/tubulin-prevents-toxic-brain-protein-clumps-linked-to-alzheimer-s-and-parkinson-ea613fc4792fea2dPharma Surgeen2026-06-21T13:08:10.000ZTubulin prevents toxic brain protein clumps linked to Alzheimer’s and Parkinson’shttps://www.pharmaradar360.com/article/yale-study-finds-nearly-half-of-older-adults-improved-with-age-6c6d331c4d824a09Pharma Surgeen2026-06-21T10:02:10.000ZYale study finds nearly half of older adults improved with agehttps://www.pharmaradar360.com/article/nhsggc-team-provides-vital-skin-cancer-support-as-demand-grows-4ea9e1b316c836fdPharma Surgeen2026-06-21T08:30:00.000ZNHSGGC team provides vital skin cancer support as demand growshttps://www.pharmaradar360.com/article/scientists-discover-neurons-must-break-their-dna-to-build-the-brain-8ed705383cda1371Pharma Surgeen2026-06-21T06:30:35.000ZScientists discover neurons must break their DNA to build the brainhttps://www.pharmaradar360.com/article/major-review-finds-vaping-likely-causes-lung-and-oral-cancer-a62ed56320212583Pharma Surgeen2026-06-21T05:26:23.000ZMajor review finds vaping likely causes lung and oral cancerhttps://www.pharmaradar360.com/article/drug-label-update-unspecified-product-b40ab5f2bc87a1ebPharma Surgeen2026-06-21T00:00:00.000ZDrug label update: unspecified producthttps://www.pharmaradar360.com/article/scientists-found-a-cannabis-compound-that-relieves-pain-without-the-high-40735f2b86392634Pharma Surgeen2026-06-20T15:33:51.000ZScientists found a cannabis compound that relieves pain without the highhttps://www.pharmaradar360.com/article/this-dna-repair-gene-went-rogue-and-exposed-a-cancer-weakness-c06077b5d7503918Pharma Surgeen2026-06-20T12:27:35.000ZThis DNA repair gene went rogue and exposed a cancer weakness